Logo image of VIV.PA

VIVENDI SE (VIV.PA) Stock Fundamental Analysis

Europe - EPA:VIV - FR0000127771 - Common Stock

3.116 EUR
+0.07 (+2.16%)
Last: 10/2/2025, 5:29:50 PM
Fundamental Rating

2

VIV gets a fundamental rating of 2 out of 10. The analysis compared the fundamentals against 43 industry peers in the Entertainment industry. The financial health of VIV is average, but there are quite some concerns on its profitability. VIV has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

1

1. Profitability

1.1 Basic Checks

VIV had negative earnings in the past year.
VIV had a positive operating cash flow in the past year.
In multiple years VIV reported negative net income over the last 5 years.
In the past 5 years VIV always reported a positive cash flow from operatings.
VIV.PA Yearly Net Income VS EBIT VS OCF VS FCFVIV.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10B 20B

1.2 Ratios

Looking at the Return On Assets, with a value of -81.94%, VIV is doing worse than 90.70% of the companies in the same industry.
VIV has a worse Return On Equity (-124.64%) than 74.42% of its industry peers.
Industry RankSector Rank
ROA -81.94%
ROE -124.64%
ROIC N/A
ROA(3y)-25.96%
ROA(5y)-0.02%
ROE(3y)-44.73%
ROE(5y)1.01%
ROIC(3y)N/A
ROIC(5y)N/A
VIV.PA Yearly ROA, ROE, ROICVIV.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50 -50 100 -100

1.3 Margins

With a Gross Margin value of 28.96%, VIV is not doing good in the industry: 81.40% of the companies in the same industry are doing better.
In the last couple of years the Gross Margin of VIV has declined.
VIV does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 28.96%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-13.13%
GM growth 5Y-8.18%
VIV.PA Yearly Profit, Operating, Gross MarginsVIV.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -500 -1K -1.5K -2K

4

2. Health

2.1 Basic Checks

VIV does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, VIV has less shares outstanding
The number of shares outstanding for VIV has been reduced compared to 5 years ago.
VIV has a worse debt/assets ratio than last year.
VIV.PA Yearly Shares OutstandingVIV.PA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B
VIV.PA Yearly Total Debt VS Total AssetsVIV.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10B 20B 30B

2.2 Solvency

Based on the Altman-Z score of 1.35, we must say that VIV is in the distress zone and has some risk of bankruptcy.
VIV's Altman-Z score of 1.35 is in line compared to the rest of the industry. VIV outperforms 55.81% of its industry peers.
The Debt to FCF ratio of VIV is 1.38, which is an excellent value as it means it would take VIV, only 1.38 years of fcf income to pay off all of its debts.
VIV's Debt to FCF ratio of 1.38 is amongst the best of the industry. VIV outperforms 81.40% of its industry peers.
VIV has a Debt/Equity ratio of 0.39. This is a healthy value indicating a solid balance between debt and equity.
VIV's Debt to Equity ratio of 0.39 is fine compared to the rest of the industry. VIV outperforms 60.47% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.39
Debt/FCF 1.38
Altman-Z 1.35
ROIC/WACCN/A
WACC6.06%
VIV.PA Yearly LT Debt VS Equity VS FCFVIV.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5B 10B 15B 20B

2.3 Liquidity

A Current Ratio of 0.51 indicates that VIV may have some problems paying its short term obligations.
With a Current ratio value of 0.51, VIV is not doing good in the industry: 76.74% of the companies in the same industry are doing better.
A Quick Ratio of 0.51 indicates that VIV may have some problems paying its short term obligations.
With a Quick ratio value of 0.51, VIV is not doing good in the industry: 74.42% of the companies in the same industry are doing better.
Industry RankSector Rank
Current Ratio 0.51
Quick Ratio 0.51
VIV.PA Yearly Current Assets VS Current LiabilitesVIV.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5B 10B

0

3. Growth

3.1 Past

VIV shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -1628.21%.
Looking at the last year, VIV shows a decrease in Revenue. The Revenue has decreased by -4.81% in the last year.
The Revenue for VIV have been decreasing by -54.89% on average. This is quite bad
EPS 1Y (TTM)-1628.21%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-80.64%
Revenue 1Y (TTM)-4.81%
Revenue growth 3Y-67.58%
Revenue growth 5Y-54.89%
Sales Q2Q%-98.4%

3.2 Future

VIV is expected to show a small growth in Earnings Per Share. In the coming years, the EPS will grow by 2.91% yearly.
Based on estimates for the next years, VIV will show a very negative growth in Revenue. The Revenue will decrease by -66.29% on average per year.
EPS Next Y-61.11%
EPS Next 2Y-9.95%
EPS Next 3Y2.91%
EPS Next 5YN/A
Revenue Next Year-96.38%
Revenue Next 2Y-80.65%
Revenue Next 3Y-66.29%
Revenue Next 5YN/A

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
VIV.PA Yearly Revenue VS EstimatesVIV.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 5B 10B 15B
VIV.PA Yearly EPS VS EstimatesVIV.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0.2 0.4 0.6 0.8 1

2

4. Valuation

4.1 Price/Earnings Ratio

VIV reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
VIV is valuated quite expensively with a Price/Forward Earnings ratio of 32.52.
Compared to the rest of the industry, the Price/Forward Earnings ratio of VIV indicates a somewhat cheap valuation: VIV is cheaper than 69.77% of the companies listed in the same industry.
Compared to an average S&P500 Price/Forward Earnings ratio of 23.21, VIV is valued a bit more expensive.
Industry RankSector Rank
PE N/A
Fwd PE 32.52
VIV.PA Price Earnings VS Forward Price EarningsVIV.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30 40

4.2 Price Multiples

Compared to the rest of the industry, the Price/Free Cash Flow ratio of VIV indicates a rather cheap valuation: VIV is cheaper than 93.02% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 2.24
EV/EBITDA N/A
VIV.PA Per share dataVIV.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 -2 4 -4

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-9.95%
EPS Next 3Y2.91%

2

5. Dividend

5.1 Amount

VIV has a Yearly Dividend Yield of 1.37%. Purely for dividend investing, there may be better candidates out there.
VIV's Dividend Yield is a higher than the industry average which is at 2.36.
With a Dividend Yield of 1.37, VIV pays less dividend than the S&P500 average, which is at 2.41.
Industry RankSector Rank
Dividend Yield 1.37%

5.2 History

The dividend of VIV decreases each year by -13.55%.
Dividend Growth(5Y)-13.55%
Div Incr Years0
Div Non Decr Years2
VIV.PA Yearly Dividends per shareVIV.PA Yearly Dividends per shareYearly Dividends per share 2019 2020 2021 2022 2023 2024 2025 0.1 0.2 0.3 0.4 0.5

5.3 Sustainability

VIV has negative earnings and hence a negative payout ratio. The dividend may be in danger.
DP-0.67%
EPS Next 2Y-9.95%
EPS Next 3Y2.91%
VIV.PA Yearly Income VS Free CF VS DividendVIV.PA Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10B 20B

VIVENDI SE

EPA:VIV (10/2/2025, 5:29:50 PM)

3.116

+0.07 (+2.16%)

Chartmill FA Rating
GICS IndustryGroupMedia & Entertainment
GICS IndustryEntertainment
Earnings (Last)07-31 2025-07-31
Earnings (Next)10-20 2025-10-20
Inst Owners31.09%
Inst Owner ChangeN/A
Ins Owners30.02%
Ins Owner ChangeN/A
Market Cap3.21B
Analysts75.71
Price Target3.7 (18.74%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 1.37%
Yearly Dividend0.25
Dividend Growth(5Y)-13.55%
DP-0.67%
Div Incr Years0
Div Non Decr Years2
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)20.03%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)-39.64%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0.68%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 32.52
P/S 10.81
P/FCF 2.24
P/OCF 2.75
P/B 0.67
P/tB 0.71
EV/EBITDA N/A
EPS(TTM)-5.96
EYN/A
EPS(NY)0.1
Fwd EY3.08%
FCF(TTM)1.39
FCFY44.62%
OCF(TTM)1.13
OCFY36.3%
SpS0.29
BVpS4.68
TBVpS4.39
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -81.94%
ROE -124.64%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 28.96%
FCFM 482.16%
ROA(3y)-25.96%
ROA(5y)-0.02%
ROE(3y)-44.73%
ROE(5y)1.01%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-13.13%
GM growth 5Y-8.18%
F-Score4
Asset Turnover0.04
Health
Industry RankSector Rank
Debt/Equity 0.39
Debt/FCF 1.38
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales 89.9%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.51
Quick Ratio 0.51
Altman-Z 1.35
F-Score4
WACC6.06%
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)44.94%
Cap/Sales(5y)29.03%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-1628.21%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-80.64%
EPS Next Y-61.11%
EPS Next 2Y-9.95%
EPS Next 3Y2.91%
EPS Next 5YN/A
Revenue 1Y (TTM)-4.81%
Revenue growth 3Y-67.58%
Revenue growth 5Y-54.89%
Sales Q2Q%-98.4%
Revenue Next Year-96.38%
Revenue Next 2Y-80.65%
Revenue Next 3Y-66.29%
Revenue Next 5YN/A
EBIT growth 1Y-58.9%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year49.85%
EBIT Next 3Y27.57%
EBIT Next 5YN/A
FCF growth 1Y1178.57%
FCF growth 3Y16%
FCF growth 5Y16.53%
OCF growth 1Y133%
OCF growth 3Y3.97%
OCF growth 5Y7.73%